LC-MS bioanalysis of targeted nasal galantamine bound chitosan nanoparticles in rats’ brain homogenate and plasma
Author:
Funder
Academy of Scientific Research and Technology
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry,Analytical Chemistry
Link
https://link.springer.com/content/pdf/10.1007/s00216-021-03487-1.pdf
Reference44 articles.
1. Thompson CA. FDA approves galantamine for Alzheimer's disease. Am J Health Syst Pharm. 2001;58(8):649.
2. Prvulovic D, Hampel H, Pantel J. Galantamine for Alzheimer's disease. Expert Opin Drug Metab Toxicol. 2010;6(3):345–54.
3. Farlow MR. Clinical pharmacokinetics of galantamine. Clin Pharmacokinet. 2003;42(15):1383–92.
4. Lane M, Carter D, Pescrille JD, Aracava Y, Fawcett WP, Basinger GW, et al. Oral pretreatment with galantamine effectively mitigates the acute toxicity of a supralethal dose of soman in cynomolgus monkeys posttreated with conventional antidotes. J Pharmacol Exp Ther. 2020;375(1):115–26.
5. Albuquerque EX, Pereira EFR, Aracava Y, Fawcett WP, Oliveira M, Randall WR, et al. Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents. Proc Natl Acad Sci USA. 2006;103(35):13220–5.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A review of chitosan-based nanocarriers as drug delivery systems for brain diseases: Critical challenges, outlooks and promises;International Journal of Biological Macromolecules;2024-10
2. Chitosan Nanoparticles for Intranasal Drug Delivery;Pharmaceutics;2024-05-31
3. Revealing the potential bioactive components and mechanism of Qianhua Gout Capsules in the treatment of gouty arthritis through network pharmacology, molecular docking and pharmacodynamic study strategies;Heliyon;2024-05
4. MSGCA: Drug-Disease Associations Prediction Based on Multi-Similarities Graph Convolutional Autoencoder;IEEE Journal of Biomedical and Health Informatics;2023-07
5. Chitosan-Based Nanoparticles for Targeted Nasal Galantamine Delivery as a Promising Tool in Alzheimer’s Disease Therapy;Pharmaceutics;2023-03-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3